9 patents
Utility
Methods of Treating Intraocular Pressure with Activators of TIE-2
14 Dec 23
Disclosed herein are compounds effective for activation of Tie-2 and inhibition of HPTP-beta.
Kevin PETERS
Filed: 21 Apr 23
Utility
Formulations of TIE-2 Activators and Methods of Use Thereof
4 May 23
Disclosed herein are compounds effective for activation of Tie-2 and inhibition of HPTPβ.
Kevin PETERS
Filed: 15 Jun 22
Utility
HUMANIZED MONOCLONAL ANTIBODIES THAT TARGET VE-PTP (HPTP-Beta)
4 May 23
The disclosure provides compositions and methods for the treatment of ocular conditions associated with angiogenesis comprising administering an antibody that targets a tyrosine phosphatase inhibitor in a subject.
Kevin PETERS, Michael Allen FLYNN
Filed: 27 May 22
Utility
Injector for Delivering Implants
6 Apr 23
An injector includes a push rod, a magazine tube, a gate, a cannula and an actuator.
Michelle HOWARD-SPARKS, Said SAIM, Amelia SCHILLING, Dario PAGGIARINO, Nathan ROLLINS, Evan Hunter WILLIAMS, Phillip HALBERT, Daniel P. SMITH, Michael W. METZ, Dustin GAIDOS, Joshua MARTIN
Filed: 3 Oct 22
Utility
Bioerodible Drug Delivery Devices
30 Mar 23
This invention relates to a bioerodible drug delivery device that can be implanted in a patient at or near an area in need of treatment.
Hong GUO, Jianbing CHEN
Filed: 4 Oct 22
Utility
Human Protein Tyrosine Phosphatase Inhibitors and Methods of Use
1 Dec 22
The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis.
Jeffrey Lyle Gray, Kande K.D. Amarasinghe, Cynthia Monesa Clark, Ryan Matthew Nichols, Matthew B. Maier
Filed: 25 Feb 22
Utility
Compositions, Formulations and Methods for Treating Ocular Diseases
1 Sep 22
Disclosed herein are compounds effective for activation of Tie-2 and inhibition of HPTP-beta.
Kevin PETERS, Robert SHALWITZ, John JANUSZ, Alexander SMITH
Filed: 3 Mar 22
Utility
Bioerodible Drug Delivery Devices
30 Jun 22
This invention relates to a bioerodible drug delivery device that can be implanted in a patient at or near an area in need of treatment.
Hong Guo, Jianbing CHEN
Filed: 17 Mar 22
Utility
Bioerodible Ocular Drug Delivery Insert and Therapeutic Method
2 Jun 22
This invention relates to implantable bioerodible inserts for delivering an active pharmaceutical ingredient to the eye.
Said SAIM, Michelle SPARKS, Dario PAGGIARINO, Basel KARZOUN
Filed: 14 Feb 22
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first